← All trials
NCT01113346
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2010
- Primary completion
- Dec 1, 2010
- Completion date
- Feb 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Avva Rus, JSCLead sponsor
- Pirogov Russian National Research Medical UniversityOverall official - principal investigator
- Avva Rus, JSCStudy director
- Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G.Collaborator
- Pirogov Russian National Research Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.